Oral contraceptive formulation and risk of breast cancer
β Scribed by Polly A. Marchbanks; Kathryn M. Curtis; Michele G. Mandel; Hoyt G. Wilson; Gary Jeng; Suzanne G. Folger; Jill A. McDonald; Janet R. Daling; Leslie Bernstein; Kathleen E. Malone; Phyllis A. Wingo; Michael S. Simon; Sandra A. Norman; Brian L. Strom; Giske Ursin; Linda K. Weiss; Ronald T. Burkman; Robert Spirtas
- Book ID
- 116383052
- Publisher
- Elsevier Science
- Year
- 2012
- Tongue
- English
- Weight
- 147 KB
- Volume
- 85
- Category
- Article
- ISSN
- 0010-7824
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
A national population-based case-control study was conducted in New Zealand to assess the effects of hormonal contraception on breast-cancer risk. A total of 891 Women aged 25 to 54 with a first diagnosis of breast cancer, and 1864 control subjects, randomly selected from the electoral rolls, were i